A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach

Recruiting Observational Study
Spinal Cord Cancer Spinal Cord Neoplasm Spinal Cord Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 – 75
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Beijing Tiantan Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Spinal cord gliomas are the most common type of primary intramedullary malignant tumors, with a low incidence and a peak onset age of approximately 35 years. They are slightly more prevalent in males than females. Clinical manifestations vary depending on tumor characteristics and location, typically presenting with axial pain and displaying a tendency for unilateral, infiltrative growth. Prognosi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age between 3 and 75 years 2. Undergoing surgical resection of spinal cord tumor 3. Histopathological diagnosis of spinal cord glioma based on routine pathological examination 4. Availability of complete clinical data and willingness to participate in follow-up 5. Informed co…
Contacts

Wang Yongzhi Wang, MD

+86 13466391736

yongzhiwang_bni@163.com

CONTACT